A cadre of world-renowned researchers working in the most promising areas of cancer research have come together to work as a team at one institution Memorial Health to accelerate findings for the prevention and therapy of cancer.

The new approach to making advances in cancer research is focused on a "boundary-less" environment which the researchers expect will stimulate faster, cross-disciplinary results and increased collaboration between researchers and physicians. The "boundary-less" approach applies to all aspects of the research and even extends to the physical facility which features a laboratory that literally has no internal walls.

This team of scientists, all recruited from top institutions in the United States, is focused exclusively on translational or "bench to bedside" research of molecular genetics, allowing them to work closely with physicians to translate laboratory findings into individualized therapys, earlier diagnostics, and new cancer prevention methods for patients.

Tapped to lead Memorial Health's newly created Laboratory Research Program, Jeff Boyd, Ph.D., a distinguished scientist from Memorial-Sloan Kettering Cancer Center in New York City, selected some of the nation's top research talent including Dominique Broccoli, Ph.D., Fox Chase Cancer Center; Nagendra Ningaraj, Ph.D., Vanderbilt University; Ranjan Perera, Ph.D., Burnham Institute, La Jolla, California; Apostolos Psychogios, M.D., Harvard University; John Risinger, Ph.D., National Cancer Institute; and, Cindy Yee, Ph.D., Memorial Sloan-Kettering Cancer Center.

Utilizing the "boundary-less" approach, the researchers will help put Memorial Health's new $22 million William and Iffath Hoskins Center for Biomedical Research at the leading edge of cancer research.

"Bringing together this talented group of researchers in a shared environment conducting translational research exclusively focused on molecular genetics provides an opportunity for extraordinary synergy. It is realistic and possible that we will make discoveries that could lead to better diagnostic tests, regiments and therapys which move toward a cure," said Dr. William Hoskins, senior vice president of oncology and research at Memorial Health and director of the Curtis and Elizabeth Anderson Cancer Institute.

Jeff Boyd, Ph.D., a distinguished scientist from Memorial-Sloan Kettering Cancer Center in New York City, was tapped to lead Memorial Health's newly created Laboratory Research Program in Savannah, Ga. Dr. Click here for more information.

"Developing a Center for Biomedical Research from the ground up and recruiting internationally-renowned cancer research researchers to collaboratively move the program forward provides us with a real opportunity to raise the bar in healthcare," said Robert Colvin, president and CEO of Memorial Health.


Posted by: Jessica    Source

---